IRIS
MOSCHETTA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.003
EU - Europa 2.026
AS - Asia 1.130
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 13.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.995
CN - Cina 729
SE - Svezia 618
IT - Italia 480
SG - Singapore 315
DE - Germania 233
UA - Ucraina 196
GB - Regno Unito 171
FI - Finlandia 166
FR - Francia 43
IE - Irlanda 34
VN - Vietnam 34
BE - Belgio 28
NL - Olanda 21
IN - India 16
RU - Federazione Russa 15
BR - Brasile 10
CZ - Repubblica Ceca 9
CA - Canada 8
HK - Hong Kong 8
IR - Iran 5
JP - Giappone 5
TR - Turchia 5
CO - Colombia 3
ID - Indonesia 3
LT - Lituania 3
AT - Austria 2
BD - Bangladesh 2
EU - Europa 2
KR - Corea 2
PL - Polonia 2
PT - Portogallo 2
CH - Svizzera 1
DZ - Algeria 1
ES - Italia 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
PK - Pakistan 1
RO - Romania 1
Totale 13.175
Salva come PNG Salva come JPEG
Città #
Fairfield 1.653
Woodbridge 1.136
Houston 792
Ashburn 759
Chandler 732
Seattle 606
Cambridge 602
Wilmington 530
Nyköping 495
Jacksonville 476
Ann Arbor 464
Singapore 222
Lawrence 191
Roxbury 188
Nanjing 181
Bari 167
Beijing 133
Dearborn 125
New York 125
Des Moines 109
Inglewood 97
Princeton 89
San Diego 75
Boardman 71
Shenyang 49
Hebei 43
Santa Clara 43
London 39
Brooklyn 37
Dong Ket 34
Dublin 34
Jiaxing 33
Nanchang 32
Los Angeles 31
San Giovanni Teatino 30
Helsinki 28
Brussels 27
Cressa 24
Munich 24
Guangzhou 22
Tianjin 22
Hefei 19
Changsha 18
Redwood City 17
Jinan 15
Paris 15
Kunming 14
Indianapolis 13
Pescara 12
Brno 9
Cerignola 9
Rome 9
Ningbo 8
Pune 8
San Mateo 8
Wuhan 8
Hong Kong 7
Hounslow 7
Norwalk 7
Shanghai 7
Toronto 7
Zhengzhou 7
Acton 5
Catania 5
Chiswick 5
Frankfurt am Main 5
Jinhua 5
Lubbock 5
Ostuni 5
Prescot 5
Shenzhen 5
Toyonaka 5
Andria 4
Brescia 4
Fuzhou 4
Stimigliano 4
Taizhou 4
Auburn Hills 3
Baotou 3
Gioia Del Colle 3
Haikou 3
Herbolzheim 3
Imbersago 3
Indiana 3
Kilburn 3
Leeds 3
Marseille 3
Milan 3
Modugno 3
Mumbai 3
Parrish 3
Perugia 3
Philadelphia 3
San Giovanni la Punta 3
Tappahannock 3
Torrile 3
Yiwu 3
Alfonsine 2
Altamura 2
Ardabil 2
Totale 10.930
Salva come PNG Salva come JPEG
Nome #
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators 136
Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate 130
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19 123
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours 123
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa 121
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil 119
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations 117
Role of oleic acid in the gut-liver axis: From diet to the regulation of its synthesis via Stearoyl-CoA desaturase 1 (SCD1) 116
Atherosclerosis: lessons from LXR and the intestine. 115
Nuclear receptors in regenerating liver and hepatocellular carcinoma 115
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 114
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 114
Sindrome metabolica e lavoro 112
Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis 109
Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse 109
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes 108
Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame? 107
Bile acids lower triglyceride levels via a pathway involving FXR, SHP and SREBP1c 106
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice 105
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. 105
Adenomatous polyposis coli (APC)-induced apoptosis of HT29 colorectal cancer cells depends on mitochondrial oxidative metabolism 103
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 101
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open-label pilot trial. 100
Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice 100
Water handling and aquaporins in bile formation: recent advances and research trends 100
The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids 99
Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2 99
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. 97
Extra virgin olive oil: Lesson from nutrigenomics 97
Hepatic-specific PPARa-FGF21 action in NAFLD 96
Welcoming Foxa2 in the bile acid entourage 96
Pathophysiology of cholesterol gallstone disease 95
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. 95
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 95
PGC-1α induced browning promotes involution and inhibits lactation in mammary glands 95
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption 94
The FXR-FGF19 Gut-Liver Axis as a Novel "hepatostat" 94
Intestinal ecology in the metabolic syndrome 94
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis 94
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. 94
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio 93
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome 91
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice 91
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis 90
Preface: a special issue on nuclear receptors with a special view on the molecular basis of disease. 89
The emerging discipline of precision cooking: a suitable tool for the precision nutrition 89
null 88
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin 88
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer 87
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari 87
The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors 87
A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia 86
Bile acids and colon cancer: Solving the puzzle with nuclear receptors 86
Hepatic Niemann Pick C1-like 1: the canalicular side of the coin 85
A phylogenetic survey of biliary lipids in vertebrates 85
Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study 85
Changes of gallbladder and gastric dynamics in patients with acute hepatitis A 85
Primary sclerosing cholangitis: updates in diagnosis and therapy. 84
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants 83
Linking transcription to physiology in lipidomics 83
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis 83
Intestinal nuclear receptors in HDL cholesterol metabolism. 83
Nuclear receptors and cholesterol metabolism in the intestine 82
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link 81
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR? 81
null 81
null 80
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 80
Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles 79
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis 79
Micellar lipid composition profoundly affects LXR-dependent cholesterol transport across CaCo2 cells 79
Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms 79
A translational view on the biliary lipid secretory network 79
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD) 79
Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice 79
Nuclear bile acid receptor FXR as pharmacological target: are we there yet? 79
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure 79
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis. 79
Nuclear bile acid receptor FXR protects against intestinal tumorigenesis 78
Taurodeoxycholate cytotoxic and sphingomyelin protective effects in isolated human colon mucosa 77
Potential role of the vitamin D receptor in control of cholesterol levels. 77
LA SINDROME METABOLICA NEGLI ADDETTI ALLA PESCA MARITTIMA 77
null 76
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1 76
Tissue-specific actions of FXR in metabolism and cancer. 75
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. 75
Cholesterol gallstone disease 74
Pathways of cholesterol crystallization in model bile and native bile 74
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice 74
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes 74
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 73
null 72
Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction 71
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor 71
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver 71
From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease 70
Severe impairment of postprandial cholecystokinin release and gallbladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR 70
Coordinate regulation of gallbladder motor function in the gut-liver axis 69
Proteomics for the discovery of nuclear bile acid receptor FXR targets 69
null 68
Totale 9.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.227 0 0 0 0 347 297 395 320 380 148 252 88
2020/20212.306 149 147 155 156 427 119 242 164 185 283 157 122
2021/20221.594 148 187 31 65 59 191 51 90 113 125 236 298
2022/20232.118 333 225 138 158 223 304 17 256 342 22 51 49
2023/2024850 52 169 37 49 68 209 33 53 7 29 41 103
2024/2025719 149 30 319 145 76 0 0 0 0 0 0 0
Totale 13.868